<DOC>
	<DOC>NCT01798498</DOC>
	<brief_summary>The aim of this clinical trial is to evaluate the efficacy and safety of Princess® VOLUME for the correction of nasolabial folds.</brief_summary>
	<brief_title>Study for the Evaluation of the Efficacy and Safety of the Dermal Filler Princess® VOLUME in Nasolabial Folds</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Major Male or female subjects between 30 years and 65 years Wrinkle score of at least 2 according to the Modified Fitzpatrick Wrinkle Scale (MFWS) Major For females: pregnancy, lactating, planned pregnancy or unwilling to use contraceptives History of allergic reaction to hyaluronic acid products Facial surgery or implantation of dermal fillers in the nasolabial region within the last 24 months Skin of the nasolabial region affected by cosmetic treatments (e.g. laser therapy within the last 12 months, chemical peeling within the last 3 months, dermabrasion within the last 12 months, botulinum toxin within the last 12 months ) Connective tissue diseases Diabetes mellitus or uncontrolled systemic diseases Known human immune deficiency viruspositive individuals Presence of silicone implant or another nonabsorbable substance (permanent fillers) in the area of product application Cutaneous lesions in the evaluated area Tendency to keloid formation and/or hypertrophic scars Autoimmune disease History of allergies against cosmetic filling products and recurrent herpes simplex History of immune system degradation</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>